To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Condition: Parkinson Disease · Sponsor: Cerevance
About this study
This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Participants will be randomized to receive once-daily oral doses of either 75 milligrams (mg) CVN424 or 150 mg CVN424, or a matching placebo for 12 weeks. Participants who successfully complete this study and retain eligibility/suitability will be invited to participate in a future open-label extension (OLE) study.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (94)
| The Kirklin Clinic of UAB Hospital | Birmingham, Alabama, United States | — |
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| University of Alabama at Birmingham ALS Clinic | Birmingham, Alabama, United States | — |
| Barrow Neurological Institute | Phoenix, Arizona, United States | — |
| Muhammad Ali Parkinson Center | Phoenix, Arizona, United States | — |
| St. Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | — |
| Parkinson's Research Centers of America - Orange county | Aliso Viejo, California, United States | — |
| Parkinson's Research Centers of America - Orange County | Newport Beach, California, United States | — |
| Parkinson's Research Centers of America - Palo Alto | Palo Alto, California, United States | — |
| CenExel Rocky Mountain Clinical Research | Englewood, Colorado, United States | — |
| David and Rhoda Chase Family Movement Disorders Center - Vernon | Vernon, Connecticut, United States | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton, Florida, United States | — |
+ 82 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06553027